HTR2A and neurodegenerative disease: Among the 5-HT2 receptor subtypes, 5-HT2A is well distributed in the CNS, primarily in the brain region responsible for cognitive and learning functions making them a novel target for therapeutic development to address AD and other neurodegenerative diseases [158].